ONKOLOGIA MEDIKOA
Mutua de Terrassa
Terrassa, EspañaMutua de Terrassa -ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2014
-
Phase II study of bevacizumab, capecitabine, and oxaliplatin followed by bevacizumab plus erlotinib as first-line therapy in metastatic colorectal cancer
Oncology Research, Vol. 21, Núm. 4, pp. 181-191